Reported solid phase 1 and phase 2 results for its drug Bempedoic Acid.
Amgen is soon releasing results from a similar drug; if results are promising, $ESPR could trend up.
Also forming cup and handle pattern.
This company has shifted from Micro cap to a Small Cap, That is a big deal. Wait for it to see the profit taking (distribution). Then add some puts and ride it lower. Limit your risk with options. Do not short this for a swing trade. Use Options.